IPAR · Investment summary · as of 3 August 2026
Priced slightly ahead of what the business has demonstrated
Business type: Compounder · mature and structurally stable
The operating path required by today's price is not achievable on the evidence.
At $124.91, IPAR requires a 5% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 3%.
The two axes AGREE — growth slack -1.68pp, margin slack -1.72pp — so this is not a COHR-shaped margin story invisible to a growth ranking. Growth is declared because that is where the falsifiable disagreement sits and where the licence portfolio actually drives the outcome.
The conditions that would settle the disagreement are dated to 31 December 2031 (5.4 years), for AT LEAST ONE of the three named licences.
The strongest argument against this view: Non-renewal, or renewal on materially worse terms, of one of the three largest licences — Jimmy Choo (17% of FY2025 sales, expires 31 December 2031), Coach (15%, 30 June 2031) or Montblanc (15%, 31 December 2030).
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | The two axes AGREE — growth slack -1.68pp, margin slack -1.72pp — so this is not a COHR-shaped margin story invisible to a growth ranking. |
| What do we forecast? | Revenue growth of 3% demonstrated; a terminal operating margin of 18%; an exit multiple of 14.9x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is -1.7 percentage points. |
| What is it worth? | Twelve-month target $121.92, -2% from the struck price. Scenario-weighted expected return net of costs -2.4%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| FY2026 10-K, filed approximately 2027-03 | Consolidated net sales | FY2026 net sales at or at or below $1,545m (+3.8% versus FY2025's $1,488.5m) | FY2026 net sales at or above $1,545m (+3.8% versus FY2025's $1,488.5m) |
| FY2026 or FY2027 10-K | The terminal margin — 17.5% assumes management's own 21.0% target; a… | Promotion & advertising at or at or above 19.0% of net sales for a full year | Promotion & advertising at or below 19.0% of net sales for a full year |
| FY2026 10-K onward | The rate has drifted 7.9 -> 8.1 -> 8.2 and the terminal bridge… | Royalty expense at or below 8.6% of net sales in any full year | Royalty expense above 8.6% of net sales in any full year |
| Q3'26 and Q4'26 releases | Reported net sales growth less the stated FX contribution, quarterly… | Neither leg of the condition opposite is met at this date | Constant-currency net sales negative for two consecutive quarters |
Non-renewal, or renewal on materially worse terms, of one of the three largest licences — Jimmy Choo (17% of FY2025 sales, expires 31 December 2031), Coach (15%, 30 June 2031) or Montblanc (15%, 31 December 2030). All three are LICENSED, not owned; all three renew inside the stated horizon; together they are 47% of net sales. The named cause is a brand owner declining to renew or taking fragrance in-house at expiry — a decision made by Capri, Tapestry or Richemont, not by IPAR.
Estimated probability 20%, against the 32% level at which the position would be resized. It sits within that level.
Falsifiable and fundamental — not one of them is a price condition.
No position is taken, so there is nothing to trim. The field is stated as the ENTRY discipline that governs when this name becomes ownable — the same arithmetic run backwards. On approach to the $121.92 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Met | Is the business worth owning under its declared economic type? |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | Non-renewal, or renewal on materially worse terms, of one of the three largest licences — Jimmy Choo (17% of FY2025 sales, expires 31 December 2031), Coach (15%, 30 June 2031) or Montblanc (15%, 31 December 2030). |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -1.7 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: non-renewal, or renewal on materially worse terms, of one of the three largest licences — Jimmy Choo (17% of FY2025 sales, expires 31 December 2031), Coach (15%, 30 June 2031) or Montblanc (15%, 31 December 2030). The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $109.92, which forces an immediate review.